ＭＫ２阻害ペプチド製剤 - Moirai Matrix Incorporated

Title:

ＭＫ２阻害ペプチド製剤

Document Type and Number:

Japanese Patent JP2018502860

Kind Code:

A

Abstract:

記載される発明は、改善された安定性およびバイオアベイラビリティを有する、アミノ酸配列ＹＡＲＡＡＡＲＱＡＲＡＫＡＬＡＲＱＬＧＶＡＡ（ＳＥＱＩＤＮＯ：１）のポリペプチドまたはその機能的等価物を含む医薬製剤を提供する。【選択図】図１

More Like This:

JP2022191218	NOVEL PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
WO/1992/022577	IMMUNOGEN COMPOUNDS HAVING SPECIFICALLY AN ANTI-CYTOKINE EFFECT, METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITIONS AND KITS CONTAINING THEM
JP7213799	NON-CYTOTOXIC MODIFIED CELLS AND USES THEREOF

Inventors:

Lander Cynthia
Brophy Colleen
Peterson Karin

Application Number:

JP2017536526A

Publication Date:

February 01, 2018

Filing Date:

January 08, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Moirai Matrix Incorporated

International Classes:

A61K38/16; A61K9/12; A61K47/02; A61K47/32; A61K47/64; A61P9/00; A61P43/00; C07K7/06; C07K7/08; C07K14/00; C07K19/00; C12N9/99

Attorney, Agent or Firm:

Shinichiro Tanaka
Disciple Maru Ken
▲吉▼田和彦
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Takamitsu Hoshino

Previous Patent: 二重特異性抗体を用いた事前標的指向化による腫瘍の治療

Next Patent: 薬剤の組合せ